AJP - Endo Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (January 9, 2007). doi:10.1152/ajpendo.00504.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/5/E1288    most recent
00504.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dragøy Hafstad, A.
Right arrow Articles by Aasum, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dragøy Hafstad, A.
Right arrow Articles by Aasum, E.
Submitted on September 19, 2006
Accepted on January 6, 2007

Glucose and insulin improve cardiac efficiency and post-ischemic functional recovery in perfused hearts from type 2 diabetic (db/db) mice

Anne Dragøy Hafstad1*, Ahmed M Khalid1, Ole-Jakob How1, Terje S Larsen1, and Ellen Aasum1

1 Department of Medical Physiology, University of Tromsoe, Tromsoe, Norway

* To whom correspondence should be addressed. E-mail: anned{at}fagmed.uit.no.

Hearts from type 2 diabetic (db/db) mice demonstrate altered substrate utilization with high rates of fatty acid oxidation, decreased functional recovery following and reduced cardiac efficiency. Although db/db mice show overall insulin resistance in vivo, we recently reported that insulin induces a marked shift towards glucose oxidation in isolated perfused db/db hearts. We hypothesize that such a shift in metabolism should improve cardiac efficiency and consequently increase functional recovery following low-flow ischemia. Hearts from db/db and non-diabetic (db/+) mice were perfused with 0.7 mM palmitate plus either 5 mM glucose (G), 5 mM glucose and 300 µU/ml insulin (GI) or 33 mM glucose and 900 µU/ml insulin (HGHI). Rates of substrate oxidation and post-ischemic recovery were only moderately affected by GI and HGHI in db/+ hearts. In contrast, GI and particularly HGHI markedly increased glucose oxidation and improved post-ischemic functional recovery in db/db hearts. Cardiac efficiency was significantly improved in db/db, but not in db/+ hearts, in the presence of HGHI. In conclusion, insulin and glucose normalize cardiac metabolism, restore efficiency and improve post-ischemic recovery in type 2 diabetic mouse hearts. These findings may in part explain the beneficial effect of GIK (glucose-insulin-potassium) therapy in diabetic patients with cardiac complications.




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Gandhi, B. A. Finegan, and A. S. Clanachan
Role of glucose metabolism in the recovery of postischemic LV mechanical function: effects of insulin and other metabolic modulators
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2576 - H2586.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. F. du Toit, W. Smith, C. Muller, H. Strijdom, B. Stouthammer, A. J. Woodiwiss, G. R. Norton, and A. Lochner
Myocardial susceptibility to ischemic-reperfusion injury in a prediabetic model of dietary-induced obesity
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2336 - H2343.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
E. D. Abel, S. E. Litwin, and G. Sweeney
Cardiac Remodeling in Obesity
Physiol Rev, April 1, 2008; 88(2): 389 - 419.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Boudina and E. D. Abel
Diabetic Cardiomyopathy Revisited
Circulation, June 26, 2007; 115(25): 3213 - 3223.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.